Patents by Inventor John Burnes

John Burnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11395868
    Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: July 26, 2022
    Assignee: Medtronic, Inc.
    Inventors: Amy Roettger, VenKatesh R. Manda, John Burnes, Rebecca Poindexter, Martin T. Gerber
  • Patent number: 10967112
    Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: April 6, 2021
    Assignee: Medtronic, Inc.
    Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKatesh R. Manda, Bryant Pudil
  • Publication number: 20210008265
    Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
    Type: Application
    Filed: September 28, 2020
    Publication date: January 14, 2021
    Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKatesh R. Manda, Bryant Pudil
  • Publication number: 20200289056
    Abstract: A system and method for synchronizing patient medical parameters and dialysis parameters. The system and related method allow for the determination of the effect of dialysis on patient health. The invention also allows for the determination of whether observed patient health effects are due to specific dialysis parameters and for making necessary changes to the dialysis parameters in order to improve patient health.
    Type: Application
    Filed: February 28, 2020
    Publication date: September 17, 2020
    Applicant: Medtronic, Inc
    Inventors: John Burnes, VenKatesh Manda, Tico Blumenthal, Orhan Soykan
  • Patent number: 10743779
    Abstract: A system and method for controlling a monitoring mode or treatment mode of an implantable medical device based on the detection of an external signal. The system and related method allow for more frequent monitoring of medical parameters at times where more frequent monitoring is necessary, such as during or after a dialysis session, with less frequent monitoring at other times, allowing for a more efficient medical device. The invention also allows for the frequency or mode of treatment by the implantable medical device, or the transmission of data from the implantable medical device to be controlled based on the external signal.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: August 18, 2020
    Assignee: Medtronic, Inc.
    Inventors: John Burnes, Rebecca Poindexter, Daniel Bloomberg, Christopher M. Hobot, Roland C. Maude-Griffin
  • Publication number: 20200245927
    Abstract: A system and method for synchronizing patient medical parameters and dialysis parameters. The system and related method allow for the determination of the effect of dialysis on patient health. The invention also allows for the determination of whether observed patient health effects are due to specific dialysis parameters and for making necessary changes to the dialysis parameters in order to improve patient health.
    Type: Application
    Filed: February 28, 2020
    Publication date: August 6, 2020
    Applicant: Medtronic, Inc.
    Inventors: John Burnes, Venkatesh Manda, Tico Blumenthal, Orhan Soykan
  • Patent number: 10617349
    Abstract: A system and method for synchronizing patient medical parameters and dialysis parameters. The system and related method allow for the determination of the effect of dialysis on patient health. The invention also allows for the determination of whether observed patient health effects are due to specific dialysis parameters and for making necessary changes to the dialysis parameters in order to improve patient health.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 14, 2020
    Assignee: MEDTRONIC, INC.
    Inventors: John Burnes, VenKatesh Manda, Tico Blumenthal, Orhan Soykan
  • Publication number: 20190262529
    Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.
    Type: Application
    Filed: May 14, 2019
    Publication date: August 29, 2019
    Inventors: Amy ROETTGER, VenKatesh R. MANDA, John BURNES, Rebecca POINDEXTER, Martin T. GERBER
  • Patent number: 10335534
    Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.
    Type: Grant
    Filed: October 25, 2016
    Date of Patent: July 2, 2019
    Assignee: Medtronic, Inc.
    Inventors: Amy Roettger, VenKatesh R. Manda, John Burnes, Rebecca Poindexter, Martin T. Gerber
  • Patent number: 10293092
    Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: May 21, 2019
    Assignee: MEDTRONIC, INC.
    Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil
  • Patent number: 10179198
    Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: January 15, 2019
    Assignee: MEDTRONIC, INC.
    Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil
  • Publication number: 20180263511
    Abstract: A system and method for controlling a monitoring mode or treatment mode of an implantable medical device based on the detection of an external signal. The system and related method allow for more frequent monitoring of medical parameters at times where more frequent monitoring is necessary, such as during or after a dialysis session, with less frequent monitoring at other times, allowing for a more efficient medical device. The invention also allows for the frequency or mode of treatment by the implantable medical device, or the transmission of data from the implantable medical device to be controlled based on the external signal.
    Type: Application
    Filed: February 2, 2016
    Publication date: September 20, 2018
    Applicant: Medtronic, Inc.
    Inventors: John Burnes, Rebecca Poindexter, Daniel Bloomberg, Christopher M. Hobot, Roland C. Maude-Griffin
  • Patent number: 9968721
    Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device and control electronics configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: May 15, 2018
    Assignee: MEDTRONIC, INC.
    Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil
  • Publication number: 20170361006
    Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
    Type: Application
    Filed: September 1, 2017
    Publication date: December 21, 2017
    Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKatesh R. Manda, Bryant Pudil
  • Patent number: 9750862
    Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
    Type: Grant
    Filed: March 20, 2012
    Date of Patent: September 5, 2017
    Assignee: Medtronic, Inc.
    Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil
  • Publication number: 20170128657
    Abstract: Systems and methods are provided for determining an estimated risk of arrhythmia during or after dialysis based on changes in serum potassium concentration of a patient and an amount of fluid removed from the patient during dialysis. The systems and methods allow for a determination of a risk that arrhythmia will occur due to the changes in potassium and fluid volume of a patient during dialysis, and for optimizing a dialysis prescription in order to minimize the risk of arrhythmia.
    Type: Application
    Filed: October 25, 2016
    Publication date: May 11, 2017
    Inventors: Amy ROETTGER, VenKatesh R. MANDA, John BURNES, Rebecca POINDEXTER, Martin T. GERBER
  • Patent number: 9642960
    Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: May 9, 2017
    Assignee: MEDTRONIC, INC.
    Inventors: Martin Gerber, John Burnes, Suping Lyu, Manda R. VenKatesh, Bryant Pudil
  • Patent number: 9616107
    Abstract: Medical systems and methods for treating kidney disease alone, heart failure alone, chronic kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a natriuretic peptide such as Vessel Dilator to a subject. Methods for increasing and maintaining peptide levels at a certain concentration include direct peptide delivery via either an external or implantable programmable pump.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 11, 2017
    Assignee: Capricor Therapeutics, Inc.
    Inventors: William P. VanAntwerp, Andrew J. L. Walsh, VenKatesh R. Manda, John Burnes
  • Patent number: 9597440
    Abstract: A method includes initiating a blood fluid removal session of a patient; monitoring an indicator of tissue fluid volume of the patient, or a portion thereof, during the blood fluid removal session; monitoring an indicator of blood fluid volume of the patient during the blood fluid removal session; determining whether a ratio of the indicator of tissue fluid volume to indicator of blood fluid volume is outside of a predetermined range; and altering the rate of fluid removal during the blood fluid removal session if the ratio is determined to be outside of the predetermined range. A blood fluid removal system may be configured to carry out the method.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: March 21, 2017
    Assignee: MEDTRONIC, INC.
    Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil
  • Publication number: 20150367054
    Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
    Type: Application
    Filed: August 18, 2015
    Publication date: December 24, 2015
    Applicant: MEDTRONIC, INC.
    Inventors: Martin Gerber, John Burnes, Suping Lyu, VenKatesh R. Manda, Bryant Pudil